Pharmaceutics · 2022 · 12 citations · 40 references
MedicineBioengineeringOncologyBiomedical ImagingDrug DeliveryMolecular ImagingCancer NanomedicineInorganic NanoparticlesMagnetic Resonance ImagingNanomedicineTargeted Imaging AgentsTumor ImagingBiocompatible NanoparticlesCancer NanotherapyNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle-based Contrast AgentsNanoparticle-based ProbesSmart NanoparticlesTumor Targeting Ligands
Hydrophilic and biocompatible PAA-coated ultrasmall Gd2O3 nanoparticles (davg = 1.7 nm) were synthesized and conjugated with tumor-targeting ligands, i.e., cyclic arginylglycylaspartic acid (cRGD) and/or folic acid (FA). FA-PAA-Gd2O3 and cRGD/FA-PAA-Gd2O3 nanoparticles were successfully applied in U87MG tumor-bearing mice for tumor imaging using T1 magnetic resonance imaging (MRI). cRGD/FA-PAA-Gd2O3 nanoparticles with multiple tumor-targeting ligands exhibited higher contrasts at the tumor site than FA-PAA-Gd2O3 nanoparticles with mono tumor-targeting ligands. In addition, the cRGD/FA-PAA-Gd2O3 nanoparticles exhibited higher contrasts in all organs, especially the aorta, compared with those of the FA-PAA-Gd2O3 nanoparticles, because of the blood cell hitchhiking effect of cRGD in the cRGD/FA-PAA-Gd2O3 nanoparticles, which prolonged their circulation in the blood.
40
<b>Hard and Soft Acids and Bases</b>
Ralph G. Pearson · Journal of the American Chemical Society · 1963 · 10.2K citations
Renal clearance of quantum dots
Hak Soo Choi, Wenhao Liu, Preeti Misra et al. · Nature Biotechnology · 2007 · 4.4K citations · Full text